Membranoproliferative glomerulonephritis natural history, complications and prognosis: Difference between revisions
Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Membranoproliferative glomerulonephritis..." |
m add |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__{{Membranoproliferative glomerulonephritis}} | ||
== Overview == | |||
== Natural history == | |||
The natural history of Membranoproliferative glomerulonephritis (MPGN) is characterised by severity of clinical features which autonomously fluctuate, with very few cases of complete remission. Acute presentation and a slower reduction in renal function have seen more in children than adults. ESRD have been occurred among approximately 40% of patients within 10 years of diagnosis. Features suggestive of an adverse outcome include the nephrotic syndrome, renal dysfunction at onset, and persistent hypertension. Type II MPGN is associated with a worse prognosis, as is the presence of chronic interstitial damage on renal biopsy. In 20 - 30% of type I and 80 - 90 % type II MPGN, Membranoproliferative glomerulonephritis may recur. | |||
== Complication == | |||
Since Membranoproliferative glomerulonephritis is a complication of other disease, and individuals with primary MPGN are in minority | |||
==References== | ==References== | ||
| Line 8: | Line 13: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Revision as of 14:09, 22 July 2018
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis natural history, complications and prognosis |
|
FDA on Membranoproliferative glomerulonephritis natural history, complications and prognosis |
|
CDC on Membranoproliferative glomerulonephritis natural history, complications and prognosis |
|
Membranoproliferative glomerulonephritis natural history, complications and prognosis in the news |
|
Blogs on Membranoproliferative glomerulonephritis natural history, complications and prognosis |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
Overview
Natural history
The natural history of Membranoproliferative glomerulonephritis (MPGN) is characterised by severity of clinical features which autonomously fluctuate, with very few cases of complete remission. Acute presentation and a slower reduction in renal function have seen more in children than adults. ESRD have been occurred among approximately 40% of patients within 10 years of diagnosis. Features suggestive of an adverse outcome include the nephrotic syndrome, renal dysfunction at onset, and persistent hypertension. Type II MPGN is associated with a worse prognosis, as is the presence of chronic interstitial damage on renal biopsy. In 20 - 30% of type I and 80 - 90 % type II MPGN, Membranoproliferative glomerulonephritis may recur.
Complication
Since Membranoproliferative glomerulonephritis is a complication of other disease, and individuals with primary MPGN are in minority